In accordance, in vitro and in vivo, the combination of metformin and dexamethasone synergizes to eliminate MM cells, inhibiting cell proliferation through reduced AKT/mTOR signaling 146. The gene discussed is AKT1; the disease is Miyoshi myopathy.